Spain, Feb. 17 -- Spain based Mirum Pharmaceuticals International, B. V. has secured contract from Gerencia del Area de Salud de Badajoz for Pharmaceutical Products - Supply by exclusivity of Marralixibat drug, medicine: Livmarli(R) 9.5 mg/ml oral sun in the health area of Badajoz. The value of the contract is worth 55179072 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....